AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2012
Apr 4, 2012
29875_dirs_2012-04-04_eea0bf2e-bf2a-47fd-8d73-f422ec2068e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-04-02
Reporting Person: COSBY MARK (EVP & President-CVS/pharmacy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-02 | Common Stock (restricted) | A | 16641 | $45.07 | Acquired | 100487 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-04-02 | Stock Option | $45.07 | A | 66548 | Acquired | 2019-04-02 | Common Stock (66548) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 26888 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $35.78 | 2018-09-01 | Common Stock (172509) | 172509 | Direct |
Footnotes
F1: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017.
F2: Option becomes exercisable in four equal annual installments, commencing 4/2/2013.
F3: Option becomes exercisable in three equal installments, commencing 9/1/2012.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3